Sign Up to like & get
recommendations!
0
Published in 2021 at "Pharmaceuticals"
DOI: 10.3390/ph14030211
Abstract: Tryptophan-2,3-dioxygenase (TDO) is one of the key tryptophan-catabolizing enzymes with immunoregulatory properties in cancer. Contrary to expectation, clinical trials showed that inhibitors of the ubiquitously expressed enzyme, indoleamine-2,3-dioxygenase-1 (IDO1), do not provide benefits in melanoma…
read more here.
Keywords:
melanoma;
mel melanoma;
melanoma cells;
expression ... See more keywords